Genetic modulation of plasma fibrinogen concentrations: Possible importance of interleukin-6

Journal of Thrombosis and Thrombolysis

Volumn 3, Issue 1, 1996, Pages 51-56

  Margaglione, Maurizio ^b   Grandone, Elvira ^b   Mancini, Francesco Paolo ^b   Di Minno, Giovanni ^a  

^a Istituto di Medicina Interna e Malattie Dismetaboliche   (Italy)

^b NONE

Author keywords

Fibrinogen; Genetic modulation; Interleukin 6

Indexed keywords

FIBRINOGEN; INTERLEUKIN 6;

ATHEROSCLEROSIS; FIBRINOGEN BLOOD LEVEL; GENE EXPRESSION; GENETICS; HEART INFARCTION; HEMOSTASIS; HEREDITY; MODULATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE;

EID: 0029877123     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00226411     Document Type: Review

References (53)

1. Cook NS, Ubben D. Fibrinogen as a major risk factor in cardiovascular disease. TIPS 1990;11:444-451.
2. Di Minno G, Mancini M. Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arteriosclerosis 1990;10:1-7.
3. Meade TW, Chakrabarti R, Haines AP, et al. Hemostatic function and cardiovascular death: Early result of a prospective study. Lancet 1980;1:1050-1054.
4. Meade TW, Mellows S, Brozovic M, et al. Hemostatic function and ischemic heart disease: Principal results of the Norwich Park Study. Lancet 1986;2:533-537.
5. Wilhelmsen K, Svardsudd K, Korsan-Bengsten K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-505.
6. Balleisen L, Bailey J, Epping PH, et al. Epidemiology study on factor VII, factor VIII and fibrinogen in an industrial population. 1. Baseline data on the relation to age, gender, body weight, smoking, alcohol, pill using and menopause. Thromb Haemost 1985;54:475-479.
7. Stone MC, Thorp JM. Plasma fibrinogen: A major coronary risk factor. J R Coll Pract 1985;35:565-569.
8. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987;258:1183-1186.
9. Heirich J, Schulte H, Balleisen L, et al. Predictive value of haemostatic variables in the PROCAM study. Thromb Haemost 1991;65:815-818.
10. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking and risk of cardiovascular disease: Insights from the Framingham Study. Am Heart J 1987;113: 1006-1010.
11. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischemic heart disease. Lancet 1987;2:986-988.
12. Krobot K, Hense HW, Cremer P, et al. Determinants of plasma fibrinogen: Relation to body weight, waist to hip ratio, smoking, alcohol, age and sex. Arterioscler Thromb 1992;12:780-788.
13. Fuller JH, Keen H, Jarrett RJ, et al. Haemostatic variables associated with diabetes and its complications. Br Med J 1979;2:964-966.
14. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature. Ann Intern Med 1993;118:956-963.
15. Meade TW, Chakrabarti R, Haines AP, et al. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1979;1:153-156.
16. Hamsten A, Iselius L, de Faire U, Blomback M. Genetic and cultural inheritance of plasma fibrinogen concentrations. Lancet 1987;2:988-90.
17. Berg K, Kierulf P. DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentrations. Clin Genet 1989;36: 229-235.
18. Thompson SG, Martin JC, Meade TW. Sources of variability in coagulation factor assays. Thromb Haemost 1987;58: 1073-1077.
19. Henschen A, McDonagh J. Fibrinogen, fibrin and factor XIII. In: Zwaal RFA, Hemker HC, eds. Blood Coagulation. Amsterdam: Elsevier, 1986:171-241.
20. Hoeprich PD, Doolittle RF. Dimeric half-molecules of human fibrinogen are joined through disulphide bonds in an antiparallel orientation. Biochemistry 1983;22:2049-55.
21. Doolittle RF, Watt KWK, Cottrell BA, et al. The amino acid sequence of the α-chain of human fibrinogen. Nature 1979;280:464-468.
22. Chung DW, Harris JE, Davie EW. Nucleotide sequences of the three genes coding for human fibrinogen. In: Liu CY, Chien S, eds. Fibrinogen, Thrombosis, Coagulation and Fibrinolysis. New York: Plenum, 1990:39-48.
23. Marino MW, Fuller GM, Elder FFB. Chromosomal localisation of human and rat alpha, beta and gamma fibrinogen genes by in situ hybridation. Cytogenet Cell Genet 1986:42: 36-41.
24. Buetow KH, Shiang R, Nakamura Y, et al. A multipoint genetic map and new RFLPs for human chromosome 4. Cytogenet Cell Genet 1989;51:973.
25. Kant JA, Fornace AJ, Saxe D, et al. Evolution and organization of the fibrinogen locus on chromosome 4: Gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci USA 1985;82:2344-2348.
26. Kant JA, Lord ST, Crabtree GR. Partial mRNA sequence for human Aα, Bβ, and γ fibrinogen chains: Evolutionary and functional implications. Proc Natl Acad Sci USA 1983; 80:3953-3957.
27. Yu S, Sher B, Kudrik B, Redman C. Intracellular assembly of human fibrinogen. J Biol Chem 1984;259:10574-10581.
28. Ptashne M. How eukaryotic transcriptional activators work. Nature 1988;335:683-689.
29. Huber P, Laurent M, Dalmon J. Human β-fibrinogen gene expression. Upstream sequences involved in its tissue specific expression and its dexamethasone and interleukin 6 stimulation. J Biol Chem 1990;265:5695-5701.
30. Roy S, Mukhopadhyay G, Redman C. Regulation of fibrinogen assembly. J Biol Chem 1990;265:6389-6393.
31. Roy S, Overton O, Redman C. Overexpression of any fibrinogen chain by Hep G2 cells specifically elevates the expression of the other two chains. J Biol Chem 1994;269: 691-695.
32. Fey GH, Fuller GM. Regulation of the acute phase gene expression by inflammatory mediators. Mol Biol Med 1987; 4:323-328.
33. Hassan J, Chelucci C, Peschle C, Sorrentino V. Transforming growth factor β (TGF-β) inhibits expression of fibrinogen and factor VII in a hepatoma cell line. Thromb Haemost 1992;67:478-483.
34. Heinrich PC, Castell JV, Andus T. Interleukin 6 and the acute phase response. Biochem J 1990;265:621-636.
35. Di Minno G, Mancini M. Drugs affecting plasma fibrinogen levels. Cardiovasc Drug Ther 1992;6:319-321.
36. Humphries SE, Imam AMA, Robbins TP, et al. The identification of a DNA polymlorphism of the α fibrinogen gene and the regional assignment of the human fibronogen genes to 4q26-qter. Hum Genet 1984;68:148-153.
37. Murray JC, Buetow K, Chung D, Aschbacher A. Linkage disequilibrium of RFLP's at the beta fibrinogen (FGB) and gamma fibrinogen (FGG) loci on chromosome 4. Cytogenet Cell Genet 1986;40:707-708.
38. Aschbacher A, Buetow K, Chung D, et al. Linkage disequilibrium of RFLP's associated with α, β, and γ fibrinogen predict gene order on chromosome 4. Am J Hum Genet 1985;37:186A.
39. Thomas AE, Green FR, Kelleher CH, et al. Variation in the promoter region of the β fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 1991;65:487-490.
40. Baumann RE, Henschen AH. Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: Identification of polymorphisms at position Aα312 and Bβ448. Blood 1993;82:2117-2124.
41. Thomas AE, Green FR, Cruickshank K, Humphries SE. The HaeIII and HindIII polymorphisms of the β fibrinogen gene: Racial differences in frequency and association. Thromb Haemost 1991;65:897.
42. Humphries SE, Cook M, Dubovitz M, et al. Role of genetic variation at the fibrinogen locus in the determination of plasma fibrinogen concentrations. Lancet 1987;1:1452-1455.
43. +1689 (AvaII), and BcII (β-Fibrinogen) and TaqI (α-Fibrinogen), and their detection by PCR. Hum Mut 1994; 3:79-81.
44. Snowden C, Houlston R, Laker MF, et al. Plasma fibrinogen levels and fibrinogen genotype in non-insulin dependent diabetics. Dis Markers 1992;10:159-168.
45. Fowkes FGR, Connor JM, Smith FB, et al. Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet 1992; 339:693-696.
46. Baumann RE, Hellschen AH. Genetic variation in human Bβ fibrinogen gene promoter influences formation of a specific DNA-protein complex with the interleukin 6 response element. Thromb Haemost. 1993;69:1515A.
47. Baumann RE, Henschen AH. Linkage disequilibrium relationships among four polymorphisms within the human fibrinogen gene cluster. Hum. Genet 1994;94:165-170.
48. Connor JM, Fowkes FGR, Wood J, et al. Genetic variation at fibrinogen loci and plasma fibrinogen levels. J Med Genet 1992;29:480-482.
49. Scarabin PJ, Bara L, Ricard S, et al. Genetic variation at the β-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM study. Arteriosc Thromb 1993;13:886-891.
50. Green F, Hamsten A, Blomback M, Humprhies S. The role of β-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 1993;70: 915-920.
51. Koster T, Rosendaal FR, Reitsma PH, et al. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms. The Leyden Thrombophilia Study (LETS). Thromb Haemost 1994;71:719-722.
52. Margaglione M, Grandone E, Vecchione G, et al. Family history and plasma fibrinogen concentrations in subjects attending a metabolic ward. Thromb Haemost 1995;73: 579-583.
53. Stuart J, George AJ, Davies AJ, Aukland A, Hurlow RA. Haematological stress syndrome in atherosclerosis. J Clin Pathol 1981;34:464-467.